Delighted to share GoI's remarkable initiative to augment our basket of #COVID19vaccines

#COVIDVaccines which have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO(Emergency Use Listing) may be given EUA in India.

This decision has been taken based on the recommendations put forth by NEGVAC after comprehensive deliberations.

First 100 beneficiaries of such foreign vaccines shall be assessed for 7 days for safety outcomes before it is further rolled out within the country.

It'll be mandatory to conduct post-approval parallel bridging clinical trial as per prescribed provisions.

This decision will facilitate quicker access to foreign #COVID19vaccines by India, enhance import of bulk drug material & utilisation of domestic fill & finish capacity.